TY - JOUR TI - Prognostic significance of monoclonal gammopathy in diffuse large B-cell lymphoma AU - Papageorgiou, S.G. AU - Thomopoulos, T.P. AU - Spathis, A. AU - Bouchla, A. AU - Glezou, I. AU - Stavroulaki, G. AU - Gkontopoulos, K. AU - Bazani, E. AU - Foukas, P.G. AU - Pappa, V. JO - Journal of Hematology & Oncology PY - 2019 VL - 37 TODO - 5 SP - 634-637 PB - John Wiley and Sons Ltd SN - 1756-8722 TODO - 10.1002/hon.2685 TODO - lactate dehydrogenase; rituximab, adult; bone marrow; cancer prognosis; cancer staging; diffuse large B cell lymphoma; disease predisposition; event free survival; female; human; International Prognostic Index; lactate dehydrogenase blood level; Letter; major clinical study; male; middle aged; monoclonal immunoglobulinemia; priority journal; complication; diffuse large B cell lymphoma; disease management; health survey; incidence; outcome assessment; paraproteinemia; prognosis, Disease Management; Female; Humans; Incidence; Lymphoma, Large B-Cell, Diffuse; Male; Paraproteinemias; Patient Outcome Assessment; Prognosis; Public Health Surveillance; Rituximab TODO - null ER -